Niere und Elektrolyte, Osteoprotektion
Reference39 articles.
1. Alakel N, Middeke JM, Schetelig J, Bornhäuser M: Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. Onco Targets Ther 10 (2017) 597–605.
2. Bonifant CL, Jackson HJ, Brentjens RJ, Curran KJ: Toxicity and management in CAR T-cell therapy. Mol Ther Oncolytics 3 (2016) 16011.
3. Busch M, Wolf G: Wann sollte bei monoklonaler Gammopathie eine Nierenbiopsie erfolgen? Nephrologe 14(1) (2019) 5–13.
4. Cairo MS, Bishop M: Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127(1) (2004) 3–11. https://pubmed.ncbi.nlm.nih.gov/15384972/.
5. Canet E, Zafrani L, Lambert J et al.: Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PloS one 8(2) (2013) e55870. https://pubmed.ncbi.nlm.nih.gov/23457485/.